Objective: To describe a patient presenting with a clinically silent, incidentally found, and pathologically confirmed active demyelinating solitary cortical lesion showing MRI gadolinium contrast enhancement, in whom biopsy was performed before the radiographic appearance of disseminated white matter lesions.
relapsing-remitting MS. This study provides compelling radiographic and pathologic evidence of relapsing-remitting MS presenting with inflammatory cortical demyelination.
METHODS The biopsied brain tissue was fixed in 10%-15% formalin and embedded in paraffin. Sections were stained with hematoxylin & eosin and Luxol fast blue/periodic acid-Schiff. Immunohistochemistry was performed using an avidin-biotin technique and primary antibodies specific for proteolipid protein, 2Ј3Ј-cyclic-nucleotide 3Ј-phosphodiesterase (CNPase), neurofilament, macrophages/microglia (KiM1P), CD3ϩ T (CD3), CD8ϩ T (CD8), and B lymphocytes (CD20), and plasma cells (CD138) as described previously. 8 Case report. A 33-year-old Caucasian woman with a history of migraine and 4 months postpartum complained of sudden onset headache and right periorbital pain. She had an upper respiratory tract infection 1 week prior to symptom onset. Neurologic examination was normal. Brain MRI revealed a high signal intensity lesion on T2-weighted imaging involving the left visual association occipital cortex (figure 1, A-C) that enhanced with gadolinium (figure 1B, inset). No other lesions were noted. An open brain biopsy was performed 1 month after symptom onset to exclude neoplasm.
The biopsy revealed the presence of a hypercellular, focally destructive, cortical demyelinated lesion extending from the pial surface through all cortical layers, with extension into the cortex laterally and partially involving the subcortical white matter (figure 2, A and B). The lesion was infiltrated by phagocytic macrophages containing both early and late intracytoplasmic myelin degradation products, consistent with early-active ongoing cortical demyelination (figure 2, C-F). 9 Marked parenchymal and perivascular (Ͼ3 cell cuffs around at least one blood vessel) cortical inflammatory infiltrates were present and composed of macrophages, microglia, CD3ϩ and CD8ϩ T cells, B lymphocytes, and plasma cells (figure 3, A-I). Perivascular and parenchymal lymphocytic infiltrates in the "pure" cortical part of this subpial lesion (figure 3, A-D), although highly inflammatory, were less cellular than infiltrates located at the gray/white matter junction or in the cavitated area (figure 3, F-I). Plasma cells were largely present in the destructive regions of the cortical plaque ( figure 3E ). Neuronal injury was evidenced by the presence of scattered pyknotic neurons ( figure 3J ). Macrophages, microglia, and T lymphocytes were often seen in close apposition to neurons (figure 2H and figure 3, K-N). Foamy macrophages were also concentrated subpially in the cortical molecular layer and subarachnoid space ( figure 2G ). The destructive region was cavitated, affecting mainly the cortex, with only Following biopsy, the patient developed an incongruous right homonymous hemianopia that slowly resolved over several months. Due to persistent headaches, a CSF analysis was performed 4 months postbiopsy and demonstrated an elevated CSF immunoglobulin G synthesis rate with normal protein, glucose, cell count, and one oligoclonal band. Lyme serology was negative. Six months after biopsy, she complained of left-sided chest numbness. Spine MRI showed 2 subtle T2-weighted lesions at C4 -5 and C6 levels. Eleven months after biopsy, she developed burning dysesthesias in the lower extremities. Brain MRI revealed new periventricular T2-weighted white matter lesions. She fulfilled diagnostic criteria for relapsing-remitting MS. At last follow-up (69 months postbiopsy), brain MRI demonstrated an interval increase in the number of white matter lesions (figure 1, D-F), and she was started on glatiramer acetate.
DISCUSSION
This study provides pathologic evidence of inflammatory cortical demyelination at clinical onset of MS that preceded radiographic evidence of disseminated white matter demyelination typical of MS relapses. A recently developed cortical demyelination rodent EAE model demonstrated that cortical inflammation is early, transient, and rapidly resolving. 5 Notably, this case report is based on a brain biopsy obtained early in the disease, whereas previous studies describing noninflammatory MS cortical pathology have relied on autopsy brain sections from patients who died with chronic progressive disease. 3 The rapid resolution of cortical inflammation may in part explain these apparent discordant findings with respect to the presence of inflammation in early vs chronic cortical demyelinating lesions.
The presence of an inflammatory subpial cortical lesion associated with MRI gadolinium contrast enhancement that preceded the classic dissemination of white matter lesions suggests that inflammation-induced cortical blood-brain barrier damage and demyelination may be early pathogenic events in MS. Whereas double inversion recovery MRI techniques may enhance detectability of cortical lesions, 10 it is also possible that there is a very short window of opportunity for detecting such cortical lesions early in MS. The transient and rapidly reversible nature of cortical inflammation and demyelination in early MS 5 may preclude the development of larger, more confluent demyelinated lesions, thereby making their clinical or radiographic detection more challeng-ing, even among symptomatic patients. These atypical presentations may result in diagnostic confusion and potentially lead to unnecessary interventions. This case emphasizes the importance of considering demyelinating disease in the differential diagnosis of patients presenting with a solitary cortical enhancing lesion.
The present case report, coupled with previously published MRI data, 7 suggests that inflammatory cortical lesions at MS onset may precede the appearance of classic white matter plaques in some patients with MS. Furthermore, cortical onset MS raises interesting questions regarding the potential role of meningeal inflammation and cortical pathology in initiating and perpetuating the MS disease process. Most therapeutic, diagnostic, and research efforts have concentrated on the white matter pathology in MS. However, a better understanding of the specific factors within the cortical microenvironment that favor rapid resolution of cortical inflammation and demyelination 5 may lead to new therapeutic approaches aimed at targeting early MS cortical pathology.
